These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25566618)

  • 1. [Treatment of adenomyosis patients by bushen huoxue sanyu decoction: a clinical study].
    Cheng C; Gui T; Huang MH; Zhu L; Ma XP; Xun AH; Wan GP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1302-5. PubMed ID: 25566618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Shixiao Huoxue Decoction on pain, tumor necrosis factor-α, and interleukin-8 in patients with adenomyosis.
    Li W; Shao C; Liang J
    Am J Transl Res; 2024; 16(2):584-591. PubMed ID: 38463587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis.
    Gao Y; Shan S; Zhao X; Jiang J; Li D; Shi B
    Medicine (Baltimore); 2019 Mar; 98(11):e14579. PubMed ID: 30882624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
    Guo Y; Duan H; Cheng J; Zhang Y
    BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
    Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
    J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of prostaglandin F2α and endothelin, pulsation index and resistance index of uterine artery blood flow on dysmenorrhea patients of cold stagnation and blood stasis syndrome with Dingkun Dan].
    Ma K; Chen YX; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(23):4474-4480. PubMed ID: 29376240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporarily Blocking the Uterine Artery to Dig Out a Diffused Adenomyosis Lesion Treated Laparoscopically.
    Li Y; Qi H; Ma W; Wu C; Li X; Zhao D; Ye W; Xiang M
    J Minim Invasive Gynecol; 2017; 24(3):349-352. PubMed ID: 27702702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
    Wu J; Huang Y; Chen L; Hu J; Zou Y
    Med Sci Monit; 2018 Sep; 24():6085-6092. PubMed ID: 30171680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].
    Lou J; Huang X; Zhang L; Xu P; Zhang X; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 48(2):136-141. PubMed ID: 31309750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Implantation and Fixation of Mirena in the Treatment of Adenomyosis and its Influence on Serum Inflammatory Factors.
    Leilei G; Di X; Na L; Rong S
    Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):9-13. PubMed ID: 36495526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
    Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
    Zheng J; Xia E; Li TC; Sun X
    J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
    He SM; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis.
    Lee KH; Kim JK; Lee MA; Ko YB; Yang JB; Kang BH; Yoo HJ
    Arch Gynecol Obstet; 2016 Sep; 294(3):561-6. PubMed ID: 27155971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy Observation of Ultrasonic Conductometric Acupoint Penetration of Wenhua Zhitong Recipe for Adenomyosis Patients].
    Zhang L; Shi YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jan; 36(1):54-8. PubMed ID: 26955678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia-related hemogram, uterine artery pulsatility index, and blood pressure for the effects of Four-Agents-Decoction (Si Wu Tang) in the treatment of primary dysmenorrhea.
    Yeh LL; Liu JY; Liu YS; Lin KS; Tsai TF; Wang LH
    J Altern Complement Med; 2009 May; 15(5):531-8. PubMed ID: 19413507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.